ProHTA - Prospective Assessment of innovative Health Technology by Simulation

Djanatliev A, German R (2011)


Publication Language: English

Publication Type: Conference contribution, Abstract of a poster

Publication year: 2011

City/Town: Piscataway, NJ

Conference Proceedings Title: Proceedings of the 2011 Winter Simulation Conference (WSC '11)

Event location: Phoenix, AZ USA US

Abstract

Innovative health technology is in great demand and offers high potentials for all involved stake-holders (e.g. health industry, patients, hospitals). ProHTA is an approach that uses simulation to indicate the effects of new technologies early before the expensive and risky development pro-cess begins. Another goal is to find gaps and bottlenecks in the health care system to catch poten-tials for new health technologies. This approach uses hybrid simulation consisting of system dy-namics models for macro simulation and agent-based models to simulate individual scenarios. Example use-cases of ProHTA are in particular stroke therapy and the oncology domain. Stroke therapy will be the primary focus and known effects and data of the thrombolysis will be used to validate the simulation models before predicting the impact of new technologies. ProHTA is supported by the Federal Ministry of Education and Research (BMBF) and is a part of the Center of Excellence for Medical Technology.

Authors with CRIS profile

How to cite

APA:

Djanatliev, A., & German, R. (2011, December). ProHTA - Prospective Assessment of innovative Health Technology by Simulation. Poster presentation at Winter Simulation Conference 2011, Phoenix, AZ USA, US.

MLA:

Djanatliev, Anatoli, and Reinhard German. "ProHTA - Prospective Assessment of innovative Health Technology by Simulation." Presented at Winter Simulation Conference 2011, Phoenix, AZ USA Ed. S. Jain, R. R. Creasey, J. Himmelspach, K. P. White, and M. Fu, Piscataway, NJ, 2011.

BibTeX: Download